Interestingly, this may also underlie the observation that penetrance in Lynch syndrome is comparable in carriers of MLH1 missense alterations versus truncating alterations [68], since both essentially render the cell devoid of MLH1. The gene discussed is MLH1; the disease is Lynch syndrome.